Genomic Classification and Individualized Prognosis in Multiple Myeloma.
Saved in:
| Title: | Genomic Classification and Individualized Prognosis in Multiple Myeloma. |
|---|---|
| Authors: | Maura F; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Rajanna AR; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Ziccheddu B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Poos AM; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Derkach A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Maclachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Durante M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Diamond B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Papadimitriou M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Davies F; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Boyle EM; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Walker B; Division of Hematology Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN., Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Silva A; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Hampton O; Aster Insights, Tampa, FL., Teer JK; Department of Biostatistics & Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, FL., Siegel EM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL., Bolli N; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy., Jackson GH; Freeman Hospital, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom., Kaiser M; The Institute of Cancer Research, London, United Kingdom., Pawlyn C; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom., Cook G; Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA., Kazandjian D; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Stein C; Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA., Chesi M; Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA., Bergsagel L; Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA., Mai EK; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Goldschmidt H; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Weisel KC; Department of Oncology, Hematology and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany., Raab MS; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Van Rhee F; Myeloma Institute for Research & Therapy, University of Arkansas for Medical Sciences, Little Rock, AR., Usmani S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Shain KH; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Weinhold N; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Morgan G; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 10; Vol. 42 (11), pp. 1229-1240. Date of Electronic Publication: 2024 Jan 09. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
